Kiniksa Pharmaceuticals International (KNSA) Net Equity Issued and Repurchased (2018 - 2020)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Net Equity Issued and Repurchased came in at $118.1 million in Q3 2020, up 143.08% on a QoQ basis from $48.6 million in Q1 2019.
Kiniksa Pharmaceuticals International (KNSA) Net Equity Issued and Repurchased (2018 - 2020) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $118.1 million in Q3 2020.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $118.1 million in Q3 2020, while the trailing twelve-month figure through Dec 2020 was $118.1 million (up 143.08% YoY) and the FY2020 annual result came in at $165.7 million, up 241.03% from the prior year.
- Net Equity Issued and Repurchased advanced to $118.1 million in Q3 2020, from $48.6 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $190.8 million in Q1 2018 to a low of $48.6 million in Q1 2019.
- A 3-year average of $119.2 million and a median of $118.1 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 74.53% in 2019, down 74.53% in 2019.
- Tracing KNSA's Net Equity Issued and Repurchased over 3 years: stood at $190.8 million in 2018, then sank by 74.53% to $48.6 million in 2019, then surged by 143.08% to $118.1 million in 2020.
- The last three Net Equity Issued and Repurchased figures came in at $118.1 million (Q3 2020), $48.6 million (Q1 2019), and $190.8 million (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.09 Bn | 5.56 Bn | 220.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 118.13 Mn |
| Sep 30, 2020 | 118.13 Mn |
| Mar 31, 2019 | 48.60 Mn |
| Mar 31, 2019 | 48.60 Mn |
| Mar 31, 2018 | 190.82 Mn |
| Mar 31, 2018 | 190.82 Mn |